Search results

Technologies 2

• Extracellular Vesicles for Biomarker Detection
  A non-invasive method to identify biomarkers of disease across cell types and develop diagnostics and monitoring systems.
• Kidney Engineering Technology for New Tissue Replacement Therapies
  Trestle Biotherapeutics licensed 3D bioprinting, and stem cell and kidney organoid engineering methods to help it create kidney repair and replacement therapies. These could become new standard-of-care options beyond dialysis and kidney transplants for patients with kidney failure.

Collaborations 3

• Brigham-Wyss DxA
  The Wyss DxA's clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests.
• Biomarker Discovery Laboratory (BDL)
  Bridging the diagnostic gap from biomarker discovery to market-ready test kits and instruments through cutting-edge technology development and clinical collaboration.
• Wyss Diagnostics Accelerator (DxA)
  An initiative to enable the fast creation of diagnostic technologies to solve high-value clinical problems through deep collaborations driven by unmet diagnostic needs.

News 18

View all

• Press Release
  
  Repairing patients’ dura more durably
  March 20, 2024
• Press Release
  
  Novel test holds promise for detecting Parkinson’s disease early
  January 10, 2024
• Research Spotlights
  
  Shape-shifting immune cells offer new insights into cancer immunotherapy
  November 17, 2023

Multimedia 3

• 

  Video/Animation
  Reimagining Healthcare for Women – 52% of All Patients
  Dr. Kathryn Rexrode, Division Chief of Women’s Health at Brigham and Women’s Hospital, discusses gender and biological sex-based discrimination in medicine, the profound effect that gender and biological sex has on healthcare, the short falls in women’s health research, and why she is hopeful that healthcare will improve for women. Credit: Wyss Institute at Harvard...

• 

  Video/Animation
  2021 Kabiller Prize in Nanoscience and Nanomedicine
  David R. Walt, a Wyss Core Faculty member, member of the faculty at Harvard Medical School in the Department of Pathology, and a Howard Hughes Medical Institute Professor, is the winner of the 2021 Kabiller Prize in Nanoscience and Nanomedicine, the world’s largest monetary award for outstanding achievement in the field of nanotechnology and its...

• 

  Video/Animation
  Kidney Organiods: Flow-Enhanced Vascularization and Maturation In Vitro
  This video explains how the collaborative project created vascularized kidney organoids and how they advance the field of tissue engineering. Credit: Wyss Institute at Harvard University.

Events 5

View all

• May 28, 2019,
  1:00pm - 2:00pm
  Lecture
  
  • Add to Calendar
  • iCalendar
  • Google Calendar
  • Outlook
  SABER enables amplified and multiplexed imaging of RNA/DNA and proteins in cells and tissues
  Wyss Core Faculty member Peng Yin will be speaking at a Brigham and Women’s Clinical Pathology Conference on Tuesday, May 28th from 1 PM to 2 PM. The topic is, “SABER enables amplified and multiplexed imaging of RNA/DNA and proteins in cells and tissues.” Directions Enter the main lobby of the Brigham and Women’s Hospital... Free and open to public
• Jun 3, 2019,
  1:00pm - 2:00pm
  Lecture
  
  • Add to Calendar
  • iCalendar
  • Google Calendar
  • Outlook
  Point of Care Diagnostics Based on Synthetic Biology
  Wyss Core Faculty member James J. Collins will be speaking at a Brigham and Women’s Pathology Grand Rounds event on Monday, June 3 from 1 PM to 2 PM. The topic is, “Point of care diagnostics based on synthetic biology.”   Accreditation Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education... Free and open to public
• Feb 26, 2019,
  1:00pm - 2:00pm
  Lecture
  
  • Add to Calendar
  • iCalendar
  • Google Calendar
  • Outlook
  Synthetic Biology: Next-Generation Diagnostics Lecture
  On Tuesday, February 26, join Brigham and Women’s Hospital for the weekly Clinical Pathology Conference lecture series featuring Wyss Core Faculty member James Collins. James Collins is a founder of the field of synthetic biology and a pioneer in the application of systems biology concepts to solve major biomedical problems. His internationally acclaimed research uses network... Free and open to public